Robinhood Markets is caught in an uncomfortable triangle: shorts keep retreating, the Street remains broadly bullish, yet options traders are the most defensively positioned they have been all year — and the founders are quietly cashing out.
The options signal is the sharpest development this week. The put/call ratio jumped to 0.68 on Tuesday, nearly three standard deviations above its 20-day average of 0.65 — the highest reading of the past 52 weeks, which topped out at 0.74. That is a meaningful step-change from where it was even last week at 0.66, and it follows a pattern that has been building all month: each session since early August has printed a higher PCR than the one before. Options traders are not panicking, but they are hedging more aggressively than at any point in recent memory, and they are doing so into a stock that fell 4.9% on Tuesday alone and is now down 8.4% over the past month to $91.53.
Short interest, by contrast, tells a story of retreat rather than pressure. SI has fallen roughly 11% over the week to 4.2% of the free float — 33.3 million shares — continuing the steady unwind from above 5% in early July. The month-on-month decline is nearly 13%. Borrow conditions remain completely unthreatening: cost to borrow has edged up 21% week-on-week but remains trivially cheap at 0.47%, and availability is an expansive 1,136% of short interest, meaning lenders are sitting on more than eleven times the shares currently borrowed. The lending market is not the story here. Short sellers have stepped back, and there is no squeeze dynamic whatsoever.
The founder selling adds a layer worth noting. Co-founder Baiju Bhatt sold roughly 50,000 shares across three transactions on August 14 — close to $4.9 million combined — at prices between $95 and $98, well above where the stock trades today. CEO Vladimir Tenev reported trimming 1.3 million shares as recently as July 6. Both founders remain the third and fourth-largest holders of record with around 6% each, so these are small relative moves, and the 90-day net insider position is technically positive at $47.5 million. But the direction is consistent: insiders have been sellers, not buyers, through this pullback.
The Street's position is broadly supportive but visibly cooling. Following the Q2 earnings print on July 29 — which dropped the stock 6.6% on the day before recovering flat over five sessions — Goldman Sachs cut its target from $137 to $118, Barclays trimmed from $122 to $105, and Cantor Fitzgerald lowered to $115 from $130, all within days of the release. The consensus mean target sits near $120, implying roughly 31% upside from current levels, but Citizens stands as an outlier holding a $155 target while the cluster of post-earnings revisions have anchored the bulk of the Street between $105 and $125. Factor scores offer a mixed read: EPS momentum over 90 days ranks in the 95th percentile of the universe, and analyst recommendation differential sits at the 94th — both strong. The short score rank and utilization rank, at 44 each, are middling.
The bull case rests on Robinhood's "financial super app" trajectory — retirement accounts, high-yield cash sweep, advisory services — targeting a young, active user base with room to monetise further. Bears point to competitive pressure from established brokerages and a revenue mix still heavily tied to trading activity, which makes the top line sensitive to market conditions. Close peers were also weak on the day: IBKR dropped 4.0% and COIN fell 2.9%, suggesting sector-wide pressure rather than a HOOD-specific story. BULL, however, managed a 4.8% gain on the week, a notable divergence.
The next scheduled catalyst is Q3 earnings on November 4. Between now and then, the key variable to watch is whether that options put/call ratio — already at a 52-week high — continues to climb as the stock tests lower levels, or fades if the price stabilises above the post-earnings floor set in late July.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
